UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study

BMC medical education, 2024-02, Vol.24 (1), p.179-179

2024

Link zum Volltext

Verfügbarkeit prüfen

3D Hanging Drop Culture to Establish Prostate Cancer Organoids

3D Cell Culture, 2017, Vol.1612, p.167-175

2017

Link zum Volltext

Verfügbarkeit prüfen

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells

Oncotarget, 2014-12, Vol.5 (23), p.12043-12056

2014

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

Oncotarget, 2015-03, Vol.6 (8), p.6105-6122

2015

Link zum Volltext

Verfügbarkeit prüfen

In vitro model systems to study androgen receptor signaling in prostate cancer

Endocrine-related cancer, 2013-04, Vol.20 (2), p.R49-R64

2013

Link zum Volltext

Verfügbarkeit prüfen

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer

Urologic oncology, 2020-11, Vol.38 (11), p.801-815

2020

Link zum Volltext

Verfügbarkeit prüfen

Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells

The FEBS journal, 2016-06, Vol.283 (11), p.2181-2196

2016

Link zum Volltext

Verfügbarkeit prüfen

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells

The Prostate, 2004-02, Vol.58 (3), p.259-268

2004

Link zum Volltext

Verfügbarkeit prüfen

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

Endocrine-related cancer, 2020-03, Vol.27 (3), p.187-198

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic

European urology, 2001-09, Vol.40 (3), p.241-251

2001

Link zum Volltext

Verfügbarkeit prüfen

Calcineurin inhibitor‐induced complement system activation via ERK1/2 signalling is inhibited by SOCS‐3 in human renal tubule cells

European journal of immunology, 2018-02, Vol.48 (2), p.330-343

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer

The Journal of steroid biochemistry and molecular biology, 2013-11, Vol.138, p.248-256

2013

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

Cancer gene therapy, 2000-07, Vol.7 (7), p.997-1007

2000

Link zum Volltext

Verfügbarkeit prüfen

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo

Molecular endocrinology (Baltimore, Md.), 2015-12, Vol.29 (12), p.1694-1707

2015

Link zum Volltext

Verfügbarkeit prüfen

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

Endocrine-related cancer, 2014-04, Vol.21 (2), p.175-187

2014

Link zum Volltext

Verfügbarkeit prüfen

SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner

Laboratory investigation, 2013-01, Vol.93 (1), p.123-134

2013

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (20), p.4640-4645

1998

Link zum Volltext

Verfügbarkeit prüfen

Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP‐dependent protein kinase A

International journal of cancer, 2010-02, Vol.126 (3), p.775-789

2010

Link zum Volltext

Verfügbarkeit prüfen

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models

The Prostate, 2000-10, Vol.45 (2), p.124-131

2000

Link zum Volltext

Verfügbarkeit prüfen

Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer

Clinical prostate cancer, 2005-09, Vol.4 (2), p.124-129

2005

Link zum Volltext

Verfügbarkeit prüfen

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α5β1?

BioMed research international, 2014, Vol.2014, p.243185

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines

Cancer research (Chicago, Ill.), 1999, Vol.59 (1), p.227-233

1999

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

Cancer gene therapy, 2002-02, Vol.9 (2), p.117-125

2002

Link zum Volltext

Verfügbarkeit prüfen

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts

Future oncology (London, England), 2005-02, Vol.1 (1), p.93-101

2005

Link zum Volltext

Verfügbarkeit prüfen

Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells

Molecular carcinogenesis, 2003-08, Vol.37 (4), p.181-191

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)
Buchkapitel
(1)

Sprache

Englisch
(45)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of familiarity with the format of the exam on performance in the OSCE of undergraduate medical students - an interventional study

3D Hanging Drop Culture to Establish Prostate Cancer Organoids

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

In vitro model systems to study androgen receptor signaling in prostate cancer

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer

Oxidative phosphorylation and mitochondrial function differ between human prostate tissue and cultured cells

Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic

Calcineurin inhibitor‐induced complement system activation via ERK1/2 signalling is inhibited by SOCS‐3 in human renal tubule cells

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer

Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo

SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer

SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner

Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor

Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP‐dependent protein kinase A

Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models

Molecular Effects of the Isoflavonoid Genistein in Prostate Cancer

H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin α5β1?

Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts

Gene expression changes following androgen receptor elimination in LNCaP prostate cancer cells

Aktive Filter

Suchergebnisse filtern